NDC 50242-260

Phesgo

Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf

Phesgo is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Hyaluronidase (human Recombinant); Pertuzumab; Trastuzumab.

Product ID50242-260_04be6beb-fee6-42cb-8b8d-ee7ac8da3262
NDC50242-260
Product TypeHuman Prescription Drug
Proprietary NamePhesgo
Generic NamePertuzumab, Trastuzumab, And Hyaluronidase-zzxf
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-06-29
Marketing CategoryBLA / BLA
Application NumberBLA761170
Labeler NameGenentech, Inc.
Substance NameHYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB
Active Ingredient Strength20000 U/10mL; mg/10mL; mg/10mL
Pharm ClassesEndoglycosidase [EPC], Glycoside Hydrolases [CS], HER2/Neu/cerbB2 Antagonists [MoA], HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC], HER2/neu Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 50242-260-01

1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-01) > 10 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2020-06-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Phesgo" or generic name "Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf"

NDCBrand NameGeneric Name
50242-245Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf
50242-260Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf

Trademark Results [Phesgo]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PHESGO
PHESGO
97934470 not registered Live/Pending
Genentech, Inc.
2023-05-12
PHESGO
PHESGO
88891147 not registered Live/Pending
Genentech, Inc.
2020-04-28
PHESGO
PHESGO
88575791 not registered Live/Pending
Genentech, Inc.
2019-08-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.